Contribution of FOS in neutrophils to venous thromboembolism via miR ‐144 based on bioinformatic prediction and validation
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Ping Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The Second Hospital, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Computational Biology, MicroRNAs, Neutrophils, Proto-Oncogene Proteins c-fos. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanxi Province Youth Science and Technology Research Fund.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
The Finkel‐Biskis‐Jinkins Osteosarcoma (c‐Fos; encoded by FOS ) plays an important role in several cardiovascular diseases, including atherosclerosis and stroke. However, the relationship between FOS and venous thromboembolism (VTE) remains unknown. We identified differentially expressed genes in Gene Expression Omnibus dataset, GSE48000, comprising VTE patients and healthy individuals, and analysed them using CIBERSORT and weighted co‐expression network analysis (WGCNA). FOS and CD46 expressions were significantly downregulated (FOS p = 2.26E‐05, CD64 p = 8.83E‐05) and strongly linked to neutrophil activity in VTE. We used GSE19151 and performed PCR to confirm that FOS and CD46 had diagnostic potential for VTE; however, only FOS showed differential expression by PCR and ELISA in whole blood samples. Moreover, we found that hsa‐miR‐144 which regulates FOS expression was significantly upregulated in VTE. Furthermore, FOS expression was significantly downregulated in neutrophils of VTE patients ( p = 0.03). RNA sequencing performed on whole blood samples of VTE patients showed that FOS exerted its effects in VTE via the leptin‐mediated adipokine signalling pathway. Our results suggest that FOS and related genes or proteins can outperform traditional clinical markers and may be used as diagnostic biomarkers for VTE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, The Second Hospital, Shanxi Medical University, Taiyuan, China.
- Department of Nephrology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
- Thyroid surgery department, First Hospital of Shanxi Medical University, Taiyuan, China.
- Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Lin Zheng
Förderung
- Shanxi Province Youth Science and Technology Research Fund
Zitieren
APA
Wang, P., Zheng, L., Qi, X., Wang, H., Zhang, R., Song, L., Chen, R., Yan, S., Chang, W., Hu, J., Wang, Y., Jin, H., Shi, Y., Wu, Z., Zhao, W., Shi, P., Tian, Q., Xing, M., & Dong, H. (2024). Contribution of FOS in neutrophils to venous thromboembolism via miR ‐144 based on bioinformatic prediction and validation. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18370
Vancouver
Wang P, Zheng L, Qi X, Wang H, Zhang R, Song L, et al. Contribution of FOS in neutrophils to venous thromboembolism via miR ‐144 based on bioinformatic prediction and validation. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18370
BibTeX
@article{Wang2024,
author = {Wang, Ping and Zheng, Lin and Qi, Xiaotong and Wang, Heng and Zhang, Ruijing and Song, Liying and Chen, Ruihan and Yan, Sheng and Chang, Wenkai and Hu, Jie and Wang, Yuwen and Jin, Haijiang and Shi, Yongbin and Wu, Zhihui and Zhao, Wenbo and Shi, Peilu and Tian, Qinqin and Xing, Miao and Dong, Honglin},
title = {Contribution of FOS in neutrophils to venous thromboembolism via miR ‐144 based on bioinformatic prediction and validation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18370}
}
EUVIMED